Scanning for cancer treatment for AML
11,000 people are predicted to die from acute myeloid leukaemia (AML) in 2019, according to…
Browsing: AML
The Leukaemia Atlas: researchers unveil proteins that signal disease
Only about one in four people diagnosed with acute myelogenous leukaemia (AML) survive five years…
Researchers combine CRISPR gene-editing technology with drug discovery to understand why cancer treatment works
11,000 people are predicted to die from acute myeloid leukemia (AML) in 2019, according to…
Starving leukaemia cells by targeting amino acids
Cancer cells consume sugar at a higher rate than healthy cells, but they’re also hungry…
Drug compound could be next-generation treatment for aggressive form of leukaemia
Researchers have been struggling for years to find a treatment for patients who have a…
ASH 2018: Machine learning-based model improves prognosis accuracy for myelodysplastic syndromes
Researchers have presented at ASH 2018 in San Diego the model of using machine learning – a…
91 percent response rate for venetoclax against newly diagnosed AML in older adults
Clinical trial results published in the journal Nature Medicine show 91 percent response rate to the combination…
DNA test for predicting risk of leukaemia relapse
A group of Canadian and Korean scientists and physicians have developed the first DNA-based test…
Increased risk of myeloid blood cancers in relatives of patients
The largest ever study of its type is the first to definitively show an increased…
Taming a fatal blood cancer
When a dangerous defect on chromosome 11q23 disrupts the genetic programming of blood cells, it…